David M. Gershenson

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.740Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors

Journal of Translational Medicine(2022)10.1186/s12967-022-03820-x

Top 27%

0.740DataRank

Top 27%20 citations

Nicholas W. Bateman, Chun Wai Ng, Yvonne T.M. Tsang, Charlotte S. Sun, Joseph Celestino +16 more

Papers

Driven by 26 papers — median percentile 73. Top paper: “GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer”.

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005919

N/A

0.812DataRank · unranked

25 citations

Bradley J. Monk, Els Van Nieuwenhuysen, Kathleen N. Moore, Michel Fabbro, David M. O’Malley +16 more

Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors

Journal of Translational Medicine(2022)10.1186/s12967-022-03820-x

Top 27%

0.740DataRank

Top 27%20 citations

Nicholas W. Bateman, Chun Wai Ng, Yvonne T.M. Tsang, Charlotte S. Sun, Joseph Celestino +16 more

The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.03.018

N/A

0.415DataRank · unranked

10 citations

William P. Tew, Christopher Purdy, S. Dennis, Andrew Menzin, John L. Lovecchio +16 more

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.013

N/A

0.104DataRank · unranked

1 citations

Austin Miller, Judith A. Smith, Stuart M. Lichtman, Michael A. Bookman, Carol Aghajanian +17 more

A randomized phase III, two-arm trial of paclitaxel, carboplatin, and maintenance letrozole versus letrozole monotherapy in patients with stage II-IV, primary low-grade serous carcinoma of the ovary or peritoneum.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps5601

N/A

0DataRank · unranked

11 citations

Lilian T. Gien, Austin Miller, Al Covens, David M. Gershenson, Amanda N. Fader

Selinexor in combination with weekly paclitaxel in patients with advanced or metastatic solid tumors: Results of an open label, single-center, multiarm phase 1b study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5565

N/A

0DataRank · unranked

0 citations

Siqing Fu, Apostolia M. Tsimberidou, Sarina A. Piha‐Paul, Fechukwu Akhmedzhanov, Bülent Yılmaz +15 more

Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.005

N/A

0DataRank · unranked

16 citations

Lauren Cobb, Shannon N. Westin, Yingao Zhang, Amir A. Jazaeri, Anaís Malpica +2 more

Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.004

N/A

0DataRank · unranked

8 citations

Siqing Fu, Apostolia M. Tsimberidou, Sarina A. Piha‐Paul, Fechukwu Akhmedzhanov, Bülent Yılmaz +16 more

Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancer

Cancer(2023)10.1002/cncr.35126

N/A

0DataRank · unranked

18 citations

Anne Knisely, Naomi Adjei, Bryan Fellman, Ying Yuan, Ami Patel +16 more

Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors

American Journal of Obstetrics and Gynecology(2023)10.1016/j.ajog.2023.02.029

N/A

0DataRank · unranked

17 citations

Alejandra Flores Legarreta, Rhea Kamat, Katelyn F. Handley, Deanna Glassman, Jeffrey How +8 more

Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-22-0623

N/A

0DataRank · unranked

17 citations

Veena K. Vuttaradhi, Thomas Welte, Namrata Khurana, Joseph Celestino, Hannah C. Beird +13 more

Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.027

N/A

0DataRank · unranked

20 citations

Danielle Enserro, Matthew S. Block, Steven Waggoner, Linda Duska, Andrea E. Wahner-Hendrickson +11 more

Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors

American Journal of Obstetrics and Gynecology(2024)10.1016/j.ajog.2024.01.002

N/A

0DataRank · unranked

14 citations

Alejandra Flores Legarreta, Katelyn F. Handley, Bryan Fellman, Katherine Foster, Deanna Glassman +10 more

The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers

British Journal of Cancer(2024)10.1038/s41416-024-02668-w

N/A

0DataRank · unranked

12 citations

Yvonne T.M. Tsang, David M. Gershenson, Kwong‐Kwok Wong, Chun Wai Ng

Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2819

N/A

0DataRank · unranked

12 citations

Yingao Zhang, Heather Lin, Oriol Mirallas, Pablo Álvarez Ballesteros, Mirella Nardo +19 more

TERT promoter mutations and survival outcomes in adult-type granulosa cell tumors

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005837

N/A

0DataRank · unranked

3 citations

Alejandra Flores Legarreta, Bryan Fellman, Deanna Glassman, Jeffrey How, Veena K. Vuttaradhi +5 more

Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors

Cancer Research(2024)10.1158/0008-5472.can-24-2341

N/A

0DataRank · unranked

3 citations

Veena K. Vuttaradhi, Eleonora Khlebus, Allison L. Brodsky, Alejandra Flores Legarreta, Joseph Celestino +12 more

PPP2R1A mutations portend improved survival after cancer immunotherapy

Nature(2025)10.1038/s41586-025-09203-8

N/A

0DataRank · unranked

29 citations

Anne Knisely, Mitsutake Yano, Minghao Dang, Emily Hinchcliff, Sanghoon Lee +36 more

Survival outcomes comparing minimally invasive versus open cytoreductive surgery in recurrent adult-type granulosa cell tumors

American Journal of Obstetrics and Gynecology(2025)10.1016/j.ajog.2025.01.012

N/A

0DataRank · unranked

8 citations

Alejandra Flores Legarreta, Jeffrey How, Veena K. Vuttaradhi, Anil K. Sood, Lois M. Ramondetta +3 more

Efficacy of cyclin-dependent kinase 4/6 inhibitors in preclinical adult-type ovarian granulosa cell tumor models

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.08.024

N/A

0DataRank · unranked

3 citations

Thomas Welte, Veena K. Vuttaradhi, Xue Yang, Elio Tahan, Eleonora Khlebus +13 more

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-3042

N/A

0DataRank · unranked

2 citations

Austin Miller, Heather A. Lankes, Kwong‐Kwok Wong, William H. Rodgers, David Millan +20 more

The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.06.498

N/A

0DataRank · unranked

53 citations

Charlotte C. Sun, Revathy B. Iyer, Alpa M. Nick, Nicole D. Fleming, Shannon N. Westin +5 more

Repurposing Food and Drug Administration-approved cancer therapies: exploring endocrine and targeted pathways in low-grade serous ovarian cancer treatment

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101938

N/A

0DataRank · unranked

3 citations

Rachel N. Grisham, Robert L. Coleman, Lauren Cobb, Bradley J. Monk, Thomas J. Herzog +3 more

Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations

Scientific Reports(2020)10.1038/s41598-020-77666-y

N/A

0DataRank · unranked

12 citations

Yvonne T.M. Tsang, Sophia Lin, Sophia Pan, Tejas Medapalli, Anaís Malpica +4 more

Successful pregnancy following chemotherapy in a survivor of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): A case report and review of literature

Gynecologic Oncology Reports(2020)10.1016/j.gore.2020.100576

N/A

0DataRank · unranked

5 citations

Terri L. Woodard, Deepthi James, Dina Patel, Sarah Roder, Deborah Holman +5 more

EFFORT: EFFicacy Of adavosertib in parp ResisTance: A randomized two-arm non-comparative phase II study of adavosertib with or without olaparib in women with PARP-resistant ovarian cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5505

N/A

0DataRank · unranked

83 citations

Robert L. Coleman, Bryan Fellman, Ying Yuan, Anil K. Sood, Pamela T. Soliman +15 more

David M. Gershenson

Indexed papers

Top data-sharing exemplar

Papers